MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
DTIL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Precision BioSciences (DTIL) Ownership - Who owns Precision BioSciences?

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
302 East Pettigrew Street
Phone
+1 919 314-5512
Employees
68
Web
https://www.precisionbiosciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
179.33M
P/E Ratio
4.53
Total Cash
99.37M
Projected Growth
N/A
Total Debt
6.05M
Revenue
45.07M
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
3.85
Total Debt/Equity
N/A
Revenue/Share
2.71 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
DTIL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for DTIL
A.I. Advisor
published General Information

General Information

a developer of technology to produce custom, genome-editing enzymes for human health and biological research

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
302 East Pettigrew Street
Phone
+1 919 314-5512
Employees
68
Web
https://www.precisionbiosciences.com